Authors:
VANDERCAM B
GALA JL
GERAIN J
DEGRAUX J
BOURLOND A
COLEBUNDERS B
PIRARD C
PORTAELS F
Citation: B. Vandercam et al., ABOUT 2 CASES OF MYCOBACTERIUM-SIMIAE INFECTION IN AIDS - REVIEW OF THE PATHOGENICITY, Acta Clinica Belgica, 53(3), 1998, pp. 206-212
Authors:
GERAIN J
LIENARD D
PAMPALLONA S
BAUMGARTNER M
RUEGG C
BUURMAN WA
EGGERMONT A
LEJEUNE F
Citation: J. Gerain et al., SYSTEMIC RELEASE OF SOLUBLE TNF RECEPTORS AFTER HIGH-DOSE TNF IN ISOLATED LIMB PERFUSION, Cytokine, 9(12), 1997, pp. 1034-1042
Authors:
MICHEL O
DUCHATEAU J
PLAT G
CANTINIEAUX B
HOTIMSKY A
GERAIN J
SERGYSELS R
Citation: O. Michel et al., BLOOD INFLAMMATORY RESPONSE TO INHALED ENDOTOXIN IN NORMAL SUBJECTS (REPRINTED FROM CLINICAL AND EXPERIMENTAL ALLERGY, VOL 25, PG 73-79, 1995), Revue francaise d'allergologie et d'immunologie clinique, 36(4), 1996, pp. 425-431
Authors:
MICHEL O
DUCHATEAU J
PLAT G
CANTINIEAUX B
HOTIMSKY A
GERAIN J
SERGYSELS R
Citation: O. Michel et al., BLOOD INFLAMMATORY RESPONSE TO INHALED ENDOTOXIN IN NORMAL SUBJECTS, Clinical and experimental allergy, 25(1), 1995, pp. 73-79
Authors:
SCHENK S
LIENARD D
GERAIN J
BAUMGARTNER M
LEJEUNE FJ
CHIQUETEHRISMANN R
RUEGG C
Citation: S. Schenk et al., RAPID INCREASE IN PLASMA TENASCIN-C CONCENTRATION AFTER ISOLATED LIMBPERFUSION WITH HIGH-DOSE TUMOR-NECROSIS-FACTOR (TNF), INTERFERON-GAMMA (IFN-GAMMA) AND MELPHALAN FOR REGIONALLY ADVANCED TUMORS, International journal of cancer, 63(5), 1995, pp. 665-672
Authors:
EGGIMANN P
CHIOLERO R
CHASSOT PG
LIENARD D
GERAIN J
LEJEUNE F
Citation: P. Eggimann et al., SYSTEMIC AND HEMODYNAMIC-EFFECTS OF RECOMBINANT TUMOR-NECROSIS-FACTOR-ALPHA IN ISOLATION PERFUSION OF THE LIMBS, Chest, 107(4), 1995, pp. 1074-1082
Authors:
LEJEUNE F
LIENARD D
EGGERMONT A
KOOPS HS
ROSENKAIMER F
GERAIN J
KLAASE J
KROON B
SCHMITZ P
Citation: F. Lejeune et al., EFFICACY OF TUMOR-NECROSIS-FACTOR-ALPHA ( RTNF-ALPHA) ASSOCIATED TO INTERFERON-GAMMA (IFN-GAMMA) AND TO CHEMOTHERAPY IN ISOLATED LIMB PERFUSION FOR INOPERABLE MALIGNANT-MELANOMA, SOFT-TISSUE SARCOMA AND EPIDERMOID CARCINOMA - A 4-YEAR EXPERIENCE, Bulletin du cancer, 82(7), 1995, pp. 561-567
Authors:
LEJEUNE F
LIENARD D
EGGERMONT A
KOOPS HS
ROSENKAIMER F
GERAIN J
KLAASE J
KROON B
VANDERVEKEN J
SCHMITZ P
Citation: F. Lejeune et al., RATIONALE FOR USING TNF-ALPHA AND CHEMOTHERAPY IN REGIONAL THERAPY OFMELANOMA, Journal of cellular biochemistry, 56(1), 1994, pp. 52-61
Authors:
VANDERSCHUEREN B
DUMON JC
OLEFFE V
HEYMANS C
GERAIN J
BODY JJ
Citation: B. Vanderschueren et al., CIRCULATING CONCENTRATIONS OF INTERLEUKIN-6 IN CANCER-PATIENTS AND THEIR PATHOGENIC ROLE IN TUMOR-INDUCED HYPERCALCEMIA, Cancer immunology and immunotherapy, 39(5), 1994, pp. 286-290
Authors:
LEJEUNE F
LIENARD D
EGGERMONT A
KOOPS HS
KROON B
GERAIN J
ROSENKAIMER F
SCHMITZ P
Citation: F. Lejeune et al., CLINICAL-EXPERIENCE WITH HIGH-DOSE TUMOR-NECROSIS-FACTOR-ALPHA IN REGIONAL THERAPY OF ADVANCED MELANOMA, Circulatory shock, 43(4), 1994, pp. 191-197
Authors:
SCULIER JP
GERAIN J
BODY JJ
MARKIEWICZ E
MOMMEN P
PAESMANS M
KLASTERSKY J
Citation: Jp. Sculier et al., A PILOT-STUDY ON A MURAMYLTRIPEPTIDE LIPOPHILIC DERIVATIVE ENTRAPPED INTO LIPOSOMES (CGP-19835A LIPID) IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER, Drug investigation, 6(5), 1993, pp. 276-284